CareRx Pb Ratio vs Capex To Revenue Analysis
CRRX Stock | CAD 1.89 0.01 0.53% |
CareRx Corp financial indicator trend analysis is way more than just evaluating CareRx Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CareRx Corp is a good investment. Please check the relationship between CareRx Corp Pb Ratio and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CareRx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Pb Ratio vs Capex To Revenue
Pb Ratio vs Capex To Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CareRx Corp Pb Ratio account and Capex To Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between CareRx Corp's Pb Ratio and Capex To Revenue is -0.32. Overlapping area represents the amount of variation of Pb Ratio that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of CareRx Corp, assuming nothing else is changed. The correlation between historical values of CareRx Corp's Pb Ratio and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pb Ratio of CareRx Corp are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Pb Ratio i.e., CareRx Corp's Pb Ratio and Capex To Revenue go up and down completely randomly.
Correlation Coefficient | -0.32 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Pb Ratio
Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most indicators from CareRx Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CareRx Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CareRx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, CareRx Corp's Issuance Of Capital Stock is very stable compared to the past year. As of the 29th of November 2024, Enterprise Value Over EBITDA is likely to grow to 7.80, while Selling General Administrative is likely to drop about 28.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 262.6M | 381.7M | 370.7M | 389.3M | Depreciation And Amortization | 15.4M | 20.1M | 20.0M | 13.2M |
CareRx Corp fundamental ratios Correlations
Click cells to compare fundamentals
CareRx Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CareRx Corp fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 87.1M | 156.1M | 282.8M | 264.5M | 231.9M | 178.4M | |
Total Current Liabilities | 68.0M | 43.3M | 53.0M | 63.9M | 62.4M | 60.0M | |
Total Stockholder Equity | (20.0M) | 11.3M | 82.3M | 64.5M | 81.5M | 85.6M | |
Net Debt | 66.2M | 62.6M | 89.9M | 106.9M | 89.8M | 92.7M | |
Retained Earnings | (201.9M) | (220.2M) | (242.9M) | (277.3M) | (282.7M) | (268.6M) | |
Accounts Payable | 11.8M | 16.4M | 33.2M | 30.5M | 29.1M | 17.0M | |
Cash | 61K | 19.6M | 35.6M | 28.4M | 7.7M | 6.6M | |
Non Current Assets Total | 68.0M | 110.9M | 187.6M | 175.4M | 166.5M | 125.6M | |
Non Currrent Assets Other | (68.0M) | (110.9M) | (187.6M) | (175.4M) | (157.8M) | (149.9M) | |
Cash And Short Term Investments | 61K | 19.6M | 35.6M | 28.4M | 7.7M | 6.7M | |
Net Receivables | 12.6M | 15.4M | 38.1M | 37.3M | 36.1M | 22.2M | |
Common Stock Shares Outstanding | 11.0M | 20.3M | 34.9M | 47.6M | 57.3M | 60.2M | |
Liabilities And Stockholders Equity | 87.1M | 156.1M | 282.8M | 264.5M | 231.9M | 178.4M | |
Other Stockholder Equity | 30.1M | 41.7M | 41.8M | 34.5M | 33.6M | 33.0M | |
Total Liab | 107.0M | 144.8M | 200.5M | 200.1M | 150.4M | 156.1M | |
Total Current Assets | 19.1M | 45.2M | 95.2M | 89.2M | 65.4M | 52.8M | |
Short Long Term Debt Total | 66.2M | 85.8M | 131.4M | 135.2M | 97.5M | 139.4M | |
Other Current Liab | 3.8M | 20.9M | 18.5M | 23.4M | 21.0M | 15.5M | |
Property Plant And Equipment Net | 20.0M | 21.1M | 38.2M | 52.4M | 52.1M | 54.7M | |
Other Current Assets | 1.3M | 1.6M | 3.5M | 2.6M | 2.0M | 1.9M | |
Property Plant And Equipment Gross | 20.0M | 21.1M | 56.6M | 74.0M | 78.9M | 82.8M | |
Accumulated Other Comprehensive Income | 10.8M | (18.4M) | 9.4M | 7.5M | 7.3M | 7.7M | |
Short Term Debt | 45.6M | 6.1M | 1.3M | 10.0M | 12.4M | 11.8M | |
Intangible Assets | 18.7M | 35.3M | 54.6M | 53.0M | 44.3M | 43.7M | |
Good Will | 27.2M | 51.7M | 92.1M | 70.0M | 80.5M | 77.9M | |
Current Deferred Revenue | 11K | 6.9M | 17.3M | 13.1M | 15.1M | 15.8M | |
Non Current Liabilities Total | 39.0M | 101.5M | 147.6M | 136.2M | 87.9M | 102.5M | |
Inventory | 5.2M | 8.6M | 18.0M | 20.3M | 19.7M | 12.3M | |
Common Stock | 141.1M | 189.8M | 283.5M | 299.8M | 323.3M | 184.6M | |
Long Term Debt | 13.0M | 71.9M | 112.0M | 99.4M | 57.1M | 59.3M | |
Long Term Debt Total | 20.6M | 79.7M | 130.2M | 125.2M | 112.7M | 67.1M | |
Capital Surpluse | 30.1M | 31.4M | 32.3M | 34.5M | 39.7M | 32.0M | |
Property Plant Equipment | 20.0M | 21.1M | 38.2M | 52.4M | 60.3M | 63.3M | |
Other Liab | 18.4M | 21.7M | 17.4M | 11.0M | 9.9M | 15.6M | |
Net Tangible Assets | (65.9M) | (75.8M) | (64.4M) | (58.5M) | (67.3M) | (70.6M) | |
Capital Lease Obligations | 9.0M | 9.6M | 18.7M | 28.4M | 30.8M | 32.3M | |
Short Long Term Debt | 44.3M | 4.2M | 733K | 7.4M | 9.9M | 9.4M | |
Non Current Liabilities Other | 2.5M | 4.0M | 2.6M | 3.7M | 2.8M | 2.6M | |
Cash And Equivalents | 61K | 19.6M | 35.6M | 28.4M | 32.6M | 34.3M |
Other Information on Investing in CareRx Stock
Balance Sheet is a snapshot of the financial position of CareRx Corp at a specified time, usually calculated after every quarter, six months, or one year. CareRx Corp Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CareRx Corp and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CareRx currently owns. An asset can also be divided into two categories, current and non-current.